Skip to content

Comparison of the effect of using vitamin C and N-acetylcysteine ??in cardioplegic solution in heart surgery

Evaluation of the clinical effects of the combination of cardioplegic solution and N-acetylcysteine in comparison with the combination of cardioplegic solution and vitamin C on heart protection during the coronary artery bypass surgery by means of cardiopulmonary pump

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250112064360N1
Enrollment
70
Registered
2025-01-29
Start date
2025-02-18
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complications of coronary artery bypass surgery.

Interventions

Intervention 1: Intervention group: The intended intervention for group 1 is performed by injecting 50 mg/kg vitamin C produced by Alborz company in combination with cardioplegic solution. The dose re

Sponsors

Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1-Candidate patients for coronary artery bypass surgery who have referred to Amir El Munin Medical Center for elective coronary artery bypass surgery with informed consent. 2- Patients who are candidates for open heart surgery who have only referred for coronary artery bypass surgery and are not candidates for heart valve repair or replacement or heart wall repair. 3-Candidates for coronary artery bypass surgery who have EF>30. 4- Absence of lung, kidney, hematological and... 5- The patient's routine and preliminary tests have been obtained and there are no contraindications or problems related to heart surgery. 6- Absence of defects in the patient's PFT. 7- No history of CVA or cerebrovascular accidents in the patient. 8- Absence of stenosis in the patient's carotid artery, which has been proven by Doppler ultrasound before preparing for the operation. 9- The length of surgery should be between 5-6 hours. 10-Perform coronary artery bypass surgery in the on-pump manner. 11- The age range of patients who are candidates for coronary artery bypass surgery should be between 30-75 years.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Cardiac ejection fraction. Timepoint: before the intervention and at the end of the patient's hospitalization. Method of measurement: Echocardiography.;Length of stay in ICU. Timepoint: Based on the end of the ICU stay. Method of measurement: There is no precedent.;Mortality during and after surgery. Timepoint: Up to thirty days after surgery. Method of measurement: There is no precedent.;Frequency of AF cardiac rhythm during ICU admission. Timepoint: During the ICU stay. Method of measurement: There is no precedent.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Ghalehnoie

Arak University of Medical Sciences

ghalehnoie_a@yagoo.com+98 86 3406 4774

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026